Literature DB >> 22833278

Explaining the fibroblast growth factor paradox in osteoarthritis: lessons from conditional knockout mice.

Tonia L Vincent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22833278     DOI： 10.1002/art.34648

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Emerging targets in osteoarthritis therapy.

Authors:  Mary B Goldring; Francis Berenbaum
Journal:  Curr Opin Pharmacol       Date:  2015-04-10       Impact factor: 5.547

2.  Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation.

Authors:  D Correa; R A Somoza; P Lin; S Greenberg; E Rom; L Duesler; J F Welter; A Yayon; A I Caplan
Journal:  Osteoarthritis Cartilage       Date:  2014-11-25       Impact factor: 6.576

3.  A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis.

Authors:  Wei Xu; Yangli Xie; Quan Wang; Xiaofeng Wang; Fengtao Luo; Siru Zhou; Zuqiang Wang; Junlan Huang; Qiaoyan Tan; Min Jin; Huabing Qi; Junzhou Tang; Liang Chen; Xiaolan Du; Chengguang Zhao; Guang Liang; Lin Chen
Journal:  Sci Rep       Date:  2016-04-04       Impact factor: 4.379

Review 4.  Changes in Membrane Receptors and Ion Channels as Potential Biomarkers for Osteoarthritis.

Authors:  Rebecca Lewis; Richard Barrett-Jolley
Journal:  Front Physiol       Date:  2015-12-01       Impact factor: 4.566

5.  Dog as a Model for Osteoarthritis: The FGF4 Retrogene Insertion May Matter.

Authors:  Anna R Tellegen; Aileen J Dessing; Kaat Houben; Frank M Riemers; Laura B Creemers; Simon C Mastbergen; Björn P Meij; Alberto Miranda-Bedate; Marianna A Tryfonidou
Journal:  J Orthop Res       Date:  2019-08-13       Impact factor: 3.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.